Expand Content

Margaret Kranyak, MD


Margaret Kranyak, MD

Appointed: 1994

Margaret Kranyak, MD
Department: Radiation Oncology
Location: Fairview Hospital
Mail Code Fairview
18101 Lorain Avenue
Cleveland, OH 44111
Type of Doctor:
Adults Only

Biographical Sketch

Margaret Kranyak, MD, has been on Staff at Cleveland Clinic since 1994. She serves as Division Chief of Radiation Oncology at the Moll Pavilion, Fairview Hospital. She serves on various hospital committees, and chairs the Breast Cancer Tumor Conference and the Oncology Process Improvement Committee. Dr. Kranyak's primary interest are prostate and breast cancer, but she treats all types of cancer except for pediatric, and is considered a Generalist in Radiation Oncology.  Dr. Kranyak has recently initiated a new support program for men entitled "For Men Only" which will hopefully continue to grow.

The Moll Pavilion boasts the latest technology in external beam radiation therapy, and offers state-of-the-art treatment for the majority of patients. Special procedures such as Gamma Knife are referred to Cleveland Clinic's main campus.

Education & Fellowships

Residency - University of Virginia Health Sciences Center
Radiation Oncology
Medical School - University of Cincinnati College of Medicine
Cincinnati, OH USA
Undergraduate - University of Cincinnati
Cincinnati, OH USA


  • Radiation Oncology
  • Radiation Oncology- Hospice and Palliative Medicine

Specialty Interests

Radiation oncology for prostate cancer, brachytherapy for prostate cancer, breast cancer, palliative medicine, psychosocial aspects of cancer care, rehabilitation after treatment


  • American Society of Radiation Oncology
  • Ohio Medical Association
  • Christian Medical and Dental Association

Treatment & Services

  • Brachytherapy
  • External Beam Radiotherapy
  • General Radiation Oncology
  • Radiation Therapy

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/30/2015, Dr. Kranyak has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English